EO1001: A first-in-class irreversible pan-ErbB inhibitor with excellent brain penetration

Wang Shen, Jeffrey Bacha, Sarath Kanekal, Neil Sankar, Wang Zhen Zhong, Yasuyuki Yoshida, Tomoko Ozawa, Tsun-Wen Yao, Andrew T. Parsa, Jeffrey J. Raizer, Shi-Yuan Cheng, Alexander H. Stegh, Andrew P. Mazar, Francis J. Giles, Harry D. Pedersen, Jann N. Sarkaria, Nicholas Butowski, Theodore Nicolaides, C. David James, and Dennis Brown

American Association of Cancer Research / International Association for the Study of Lung Cancer Joint Meeting.  January 2020, San Diego, USA